financetom
Business
financetom
/
Business
/
JP Morgan Launches New ETF To Tap Into US Large-Cap Growth: JUSA Hits NYSE
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JP Morgan Launches New ETF To Tap Into US Large-Cap Growth: JUSA Hits NYSE
Mar 14, 2025 11:23 AM

Friday, JP Morgan Chase & Co.‘s J.P. Morgan Asset Management, or JPMAM, launched the JPMorgan U.S. Research Enhanced Large Cap ETF, or JUSA on the New York Stock Exchange, expanding its research enhanced ETF offerings.

This ETF is designed to offer investors a strategy for long-term capital appreciation by providing exposure to large-cap U.S. companies.

The new fund reflects JP Morgan’s leadership in active ETFs. JP Morgan stock is trading higher on Friday.

Also Read: Gold ETFs Shine As Spot Price Tops $3,000 During Safe-Haven Demand

According to John Harrington, Global Head of ETF Product at JP Morgan Asset Management, JUSA combines the firm’s decades of experience in managing research enhanced strategies with the flexibility and innovation of the active ETF structure.

“JUSA demonstrates our ability to adapt proven strategies to meet the evolving needs of investors in today’s dynamic market and is an exciting addition to our active U.S. ETF offerings,” Harrington adds.

Since the introduction of the 2019 ETF Rule, which simplified the regulatory process, there has been significant growth in the assets held by active ETFs, particularly in categories like Large Blend and Large Value.

This trend underscores the increasing investor preference for ETFs, which offer diversified, cost-effective ways to gain equity exposure.

Managed by portfolio managers Ralph Zingone and Tim Snyder, who have implemented the strategy since 1988, JUSA offers a portfolio with a slightly lower active risk budget and a broader number of holdings.

Price Action: JPM shares are trading higher by 3.09% to $232.15 at last check Friday.

Read Next:

Exclusive: What Industry Experts Are Saying About OpenAI-Oracle-Nvidia's $100-Billion Stargate Project & ETFs That Stand To Gain

Image: Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BGC Group Extends $500 Million Senior Notes Exchange Offer
BGC Group Extends $500 Million Senior Notes Exchange Offer
Oct 3, 2024
09:16 AM EDT, 09/25/2024 (MT Newswires) -- BGC Group ( BGC ) said Wednesday it has extended its offer to swap up to $500 million total principal amount of its outstanding 6.6% senior notes due 2029 for newly registered notes with identical terms. The offer will now expire at 5 pm ET on Friday, according to the company. A total...
PTC Enters Strategic Collaboration with Amazon Web Services to Accelerate Cloud Growth
PTC Enters Strategic Collaboration with Amazon Web Services to Accelerate Cloud Growth
Oct 3, 2024
09:18 AM EDT, 09/25/2024 (MT Newswires) -- PTC (PTC) said Wednesday it entered a strategic collaboration agreement with Amazon.com's ( AMZN ) Amazon Web Services unit to accelerate the growth of its Onshape cloud-native computer-aided design and product data management solution. The partnership will focus on advancing product enhancements, boosting customer adoption, and artificial intelligence initiatives, the company said. Financial...
Abivax Says Ulcerative Colitis Drug Maintained Clinical Remission at Reduced Dose
Abivax Says Ulcerative Colitis Drug Maintained Clinical Remission at Reduced Dose
Oct 3, 2024
04:13 AM EDT, 10/03/2024 (MT Newswires) -- Abivax ( ABVX ) said Thursday an interim analysis from its open-label maintenance study showed that patients with ulcerative colitis maintained clinical remission while taking its obefazimod drug at a reduced dose for up to two additional years. Patients who initially took 50 milligrams of obefazimod daily were allowed to continue treatment at...
Housing to Improve in 2025 as Bank of Canada Rate Cuts to Drive
Housing to Improve in 2025 as Bank of Canada Rate Cuts to Drive "Modest" Upturn, Says Macquarie Economist
Oct 3, 2024
09:11 AM EDT, 09/25/2024 (MT Newswires) -- Canada's housing has been stagnant in recent months as prices have meandered, home sales have stalled and renovation activity has been sluggish, said David Doyle, head of economics at Macquarie. One bright spot has been an improvement in the trend in starts, noted Doyle. In the near term, the economist anticipates sideways activity...
Copyright 2023-2026 - www.financetom.com All Rights Reserved